1. Signaling Pathways
  2. PI3K/Akt/mTOR
  3. mTOR
  4. mTOR Inhibitors

mTOR Inhibitors

mTOR

mTORC1

mTORC2

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.

mTOR Inhibitors, Activators & Modulators
Product Name mTOR mTORC1 mTORC2 Purity
Rapamycin  
mTOR, IC50: 0.1 nM (in HEK293 cells )
  ≥98.0%
Everolimus  
mTOR, IC50: 5-6 nM
  ≥98.0%
MHY1485  
mTORC1
mTORC2
99.86%
Torin 1
mTOR, IC50: 3 nM
mTORC1, IC50: 2-10 nM
mTORC2, IC50: 2-10 nM
≥98.0%
AZD-8055
mTOR, IC50: 0.8 nM
    ≥95.0%
RMC-5552  
mTORC1
  98.10%
Pomiferin
mTOR, IC50: 6.2 μM
    97.36%
Sapanisertib
mTOR, IC50: 1 nM
    ≥98.0%
Dactolisib
mTOR, IC50: 20.7 nM
    99.68%
JR-AB2-011    
mTORC2, IC50: 0.36 μM
98.53%
3BDO
mTOR
    99.91%
Temsirolimus  
mTOR, IC50: 1.76 μM
  ≥98.0%
Vistusertib
mTOR, IC50: 2.81 nM
    98.53%
Salidroside
mTOR
    ≥98.0%
Torkinib
mTOR, IC50: 8 nM
mTORC1, IC50: 30 nM
mTORC2, IC50: 58 nM
98.76%
PI-103  
mTORC1, IC50: 20 nM
mTORC2, IC50: 83 nM
98.93%
Torin 2
mTOR, IC50: 2.81 nM
mTOR, EC50: 0.25 nM (Cell Assay)
    99.93%
Omipalisib  
mTORC1, Ki: 0.18 nM
mTORC2, Ki: 0.3 nM
99.93%
L-Leucine  
mTORC1
  ≥98.0%
PF-04691502
mTOR, Ki: 16 nM
    99.64%
Dihydromyricetin  
mTORC1
mTORC2
99.79%
KU-0063794  
mTORC1, IC50: 10 nM
mTORC2, IC50: 10 nM
99.22%
Dactolisib Tosylate
mTOR, IC50: 20.7 nM
    99.88%
Samotolisib
mTOR, IC50: 165 nM
    99.42%
RapaLink-1
mTOR
    ≥98.0%
OSI-027
mTOR, IC50: 4 nM
mTORC1, IC50: 22 nM
mTORC2, IC50: 65 nM
≥98.0%
Ridaforolimus  
mTOR
  ≥98.0%
Apitolisib
mTOR, Ki: 17 nM
    98.26%
PKI-402
mTOR, IC50: 3 nM
    99.79%
Bimiralisib
mTOR, IC50: 89 nM
    98.74%
Gedatolisib
mTOR, IC50: 1.6 nM
    ≥98.0%
GSK1059615
mTOR, IC50: 12 nM
    ≥99.0%
mTOR inhibitor-3
mTOR, Ki: 1.5 nM
    99.08%
BGT226 maleate
mTOR
    99.73%
VS-5584
mTOR, IC50: 37 nM
    ≥95.0%
CC-115
mTOR, IC50: 21 nM
    98.04%
Voxtalisib
mTOR, IC50: 157 nM
mTORC1, IC50: 160 nM
mTORC2, IC50: 910 nM
99.46%
WYE-132
mTOR, IC50: 0.19 nM
    99.40%
PP121
mTOR, IC50: 10 nM
    99.08%
WYE-354
mTOR, IC50: 5 nM
    ≥98.0%
GNE-317
mTOR
    99.31%
CZ415
mTOR, pIC50: 8.07
    98.43%
GDC-0349
mTOR, Ki: 3.8 nM
    ≥95.0%
XL388
mTOR, IC50: 9.9 nM
    99.25%
HDACs/mTOR Inhibitor 1
mTOR, IC50: 1.2 nM
    99.12%
CC-223
mTOR, IC50: 16 nM
    ≥97.0%
PI-103 Hydrochloride  
mTORC1, IC50: 20 nM
mTORC2, IC50: 83 nM
98.06%
PQR620  
mTORC1
mTORC2
98.06%
Arnicolide D
mTOR
    ≥99.0%
GNE-477
mTOR, Ki: 21 nM
    98.70%
ETP-46464
mTOR, IC50: 0.6 nM
    ≥95.0%
Palomid 529  
TORC1
TORC2
99.47%
PQR530
mTOR, Kd: 0.33 nM
    99.93%
WAY-600
mTOR, IC50: 9 nM
    95.12%
hSMG-1 inhibitor 11j
mTOR, IC50: 50 nM
    99.81%
PI3K/mTOR Inhibitor-2
mTOR, IC50: 4.7 nM
    99.45%
(+)-Usnic acid  
mTORC1
mTORC2
≥99.0%
NSC781406
mTOR, IC50: 5.4 nM
    99.91%
PF-04979064
mTOR, Ki: 1.42 nM
    99.75%
Hederacolchiside A1
mTOR
    ≥99.0%
Rotundic acid
mTOR
    ≥99.0%
GNE-493
mTOR, IC50: 30 nM
    98.33%
CC-115 hydrochloride
mTOR, IC50: 21 nM
    98.23%
TML-6
mTOR
    98.34%
mTOR inhibitor-8
mTOR
    98.04%
PKI-179
mTOR, IC50: 0.42 nM
    ≥98.0%
MT 63-78  
mTORC1
  98.22%
WYE-687
mTOR, IC50: 7 nM
    97.17%
BGT226
mTOR
   
FT-1518  
mTORC1
mTORC2
mTOR inhibitor-2
mTOR, IC50: 7 nM
   
PI3K/mTOR Inhibitor-1
mTOR, IC50: 186 nM
   
PKI-179 hydrochloride
mTOR, IC50: 0.42 nM
    98.11%
PI3K/mTOR Inhibitor-3
mTOR
   
WYE-687 dihydrochloride
mTOR, IC50: 7 nM
    ≥98.0%
hSMG-1 inhibitor 11e
mTOR, IC50: 45 nM
    99.18%
PI3Kα/mTOR-IN-1
mTOR, Ki: 10.6 nM